Follow this preprint
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
Malin Hultcrantz, Joshua Richter, Cara Rosenbaum, Dhwani Patel, Eric Smith, Neha Korde, Sydney Lu, Sham Mailankody, Urvi Shah, Alexander Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkacs, Benjamin Diamond, Adriana Rossi, Roger N. Pearse, Deepu Madduri, Ajai Chari, David Kaminetsky, Marc Braunstein, Christian Gordillo, Faith Davies, Sundar Jagannath, Ruben Niesvizky, Suzanne Lentzsch, Gareth Morgan, Ola Landgren
doi: https://doi.org/10.1101/2020.06.09.20126516
Now published in Blood Cancer Discovery doi: 10.1158/2643-3230.BCD-20-0102
Malin Hultcrantz
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MD, PhDJoshua Richter
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
MDCara Rosenbaum
3Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, USA
MDDhwani Patel
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDEric Smith
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MD PhDNeha Korde
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDSydney Lu
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MD PhDSham Mailankody
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MBBSUrvi Shah
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDAlexander Lesokhin
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDHani Hassoun
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDCarlyn Tan
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDFrancesco Maura
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MDAndriy Derkacs
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Benjamin Diamond
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Adriana Rossi
3Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, USA
MDRoger N. Pearse
3Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, USA
MD PhDDeepu Madduri
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
MDAjai Chari
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
MDDavid Kaminetsky
5Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
MDMarc Braunstein
5Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
MD PhDChristian Gordillo
6Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA
Faith Davies
5Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
MDSundar Jagannath
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
MBBSRuben Niesvizky
3Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, USA
MDSuzanne Lentzsch
6Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA
MD, PhDGareth Morgan
5Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
MD, PhDOla Landgren
1Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
MD, PhD
Data Availability
Please contact the corresponding authors for questions regarding clinical data.
Posted June 11, 2020.
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
Malin Hultcrantz, Joshua Richter, Cara Rosenbaum, Dhwani Patel, Eric Smith, Neha Korde, Sydney Lu, Sham Mailankody, Urvi Shah, Alexander Lesokhin, Hani Hassoun, Carlyn Tan, Francesco Maura, Andriy Derkacs, Benjamin Diamond, Adriana Rossi, Roger N. Pearse, Deepu Madduri, Ajai Chari, David Kaminetsky, Marc Braunstein, Christian Gordillo, Faith Davies, Sundar Jagannath, Ruben Niesvizky, Suzanne Lentzsch, Gareth Morgan, Ola Landgren
medRxiv 2020.06.09.20126516; doi: https://doi.org/10.1101/2020.06.09.20126516
Now published in Blood Cancer Discovery doi: 10.1158/2643-3230.BCD-20-0102
Subject Area
Reviews and Context
1
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3193)
- Dermatology (270)
- Emergency Medicine (473)
- Epidemiology (13180)
- Forensic Medicine (19)
- Gastroenterology (883)
- Genetic and Genomic Medicine (5010)
- Geriatric Medicine (467)
- Health Economics (767)
- Health Informatics (3154)
- Health Policy (1119)
- Hematology (418)
- HIV/AIDS (992)
- Medical Education (466)
- Medical Ethics (123)
- Nephrology (512)
- Neurology (4763)
- Nursing (253)
- Nutrition (706)
- Oncology (2452)
- Ophthalmology (696)
- Orthopedics (274)
- Otolaryngology (335)
- Pain Medicine (317)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1270)
- Primary Care Research (542)
- Public and Global Health (7325)
- Radiology and Imaging (1647)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (413)
- Surgery (531)
- Toxicology (68)
- Transplantation (227)
- Urology (197)